CYLATRON Trademark

Trademark Overview

On Thursday, December 9, 2004, a trademark application was filed for CYLATRON with the United States Patent and Trademark Office. The USPTO has given the CYLATRON trademark a serial number of 78529557. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 7, 2009. This trademark is owned by SCHERING CORPORATION. The CYLATRON trademark is filed in the Pharmaceutical Products category with the following description:

LONG-ACTING BROAD SPECTRUM ANTIVIRAL AND IMMUNODULATING AGENT, NAMELY PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER
cylatron

General Information

Serial Number78529557
Word MarkCYLATRON
Filing DateThursday, December 9, 2004
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 7, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2006

Trademark Statements

Goods and ServicesLONG-ACTING BROAD SPECTRUM ANTIVIRAL AND IMMUNODULATING AGENT, NAMELY PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 20, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSCHERING CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKENILWORTH, NJ 070330530
Party NameSCHERING CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKENILWORTH, NJ 070330530

Trademark Events

Event DateEvent Description
Monday, December 7, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 7, 2009ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 26, 2009EXTENSION 5 GRANTED
Thursday, May 7, 2009EXTENSION 5 FILED
Thursday, May 7, 2009TEAS EXTENSION RECEIVED
Monday, November 3, 2008EXTENSION 4 GRANTED
Thursday, October 30, 2008EXTENSION 4 FILED
Friday, October 31, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 30, 2008TEAS EXTENSION RECEIVED
Tuesday, May 6, 2008EXTENSION 3 GRANTED
Monday, April 28, 2008EXTENSION 3 FILED
Monday, April 28, 2008TEAS EXTENSION RECEIVED
Friday, October 26, 2007EXTENSION 2 GRANTED
Monday, October 22, 2007EXTENSION 2 FILED
Monday, October 22, 2007TEAS EXTENSION RECEIVED
Monday, August 20, 2007EXTENSION 1 GRANTED
Thursday, May 3, 2007EXTENSION 1 FILED
Thursday, May 3, 2007TEAS EXTENSION RECEIVED
Tuesday, November 7, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 15, 2006PUBLISHED FOR OPPOSITION
Wednesday, July 26, 2006NOTICE OF PUBLICATION
Monday, June 26, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 23, 2006ASSIGNED TO LIE
Friday, June 16, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 15, 2006EXAMINER'S AMENDMENT ENTERED
Wednesday, June 14, 2006EXAMINERS AMENDMENT E-MAILED
Wednesday, June 14, 2006EXAMINERS AMENDMENT -WRITTEN
Friday, March 31, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 31, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 19, 2005FINAL REFUSAL MAILED
Saturday, December 17, 2005FINAL REFUSAL WRITTEN
Monday, November 28, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 23, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 23, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 15, 2005NON-FINAL ACTION MAILED
Friday, July 15, 2005NON-FINAL ACTION WRITTEN
Thursday, July 14, 2005ASSIGNED TO EXAMINER
Monday, December 20, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

cylatron pharmaceutical namely preparations treatment cancer agent immunodulating acting broad spectrum